Beyond CDI, there is growing interest in the potential use of FMT for other conditions, such as inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and even metabolic disorders like obesity and diabetes. While preliminary studies have shown promising results, more robust epidemiological data are needed to establish the efficacy and safety of FMT for these conditions.
